Mehalick David's Insider Trades & SAST Disclosures

Mehalick David's most recent trade in Coeptis Therapeutics Holdings Inc was a trade of 28,875 Non-Qualified Stock Options (right to buy) done . Disclosure was reported to the exchange on March 4, 2025.

Share

Note

This is a custom search result for pattern Mehalick David.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Coeptis Therapeutics Holdi...	David Mehalick	Director, CEO and President, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Mar 2025	28,875	200,125	-		-	Non-Qualified Stock Options (right to buy)
Coeptis Therapeutics Holdi...	David Mehalick	Director, CEO and President, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.66 per share.	05 Jan 2024	14,004	2,782,615	-	0.7	9,243	Common Stock
Coeptis Therapeutics Holdi...	Mehalick David	Director, CEO and President, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.67 per share.	05 Jan 2024	6,000	2,768,611	-	0.7	4,020	Common Stock
Coeptis Therapeutics Holdi...	David Mehalick	Director, CEO and President, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.69 per share.	05 Jan 2024	5,050	2,762,611	-	0.7	3,485	Common Stock
Coeptis Therapeutics Holdi...	David Mehalick	Director, CEO and President, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	07 Dec 2023	700,000	2,757,561	-		0	Common Stock
Coeptis Therapeutics Holdi...	David Mehalick	Director, CEO and President, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2023	375,000	375,000	-		-	Non-qualified Stock Options (right to buy)
Coeptis Therapeutics Holdi...	David Mehalick	Director, CEO and President, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2023	250,000	250,000	-		-	Incentive Stock Options (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades